Clinical trial
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical…
NCT00370851 · Shahid Beheshti University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00370851 |
|---|---|
| Title | Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial |
| Official title | Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Retinal Disease |
| Intervention type | Drug |
| Interventions | Avastin (Bevacizumab) |
| Enrollment | 82 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 1, 2006 |
| Last update posted | Nov 25, 2009 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: